PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07544056

1 development in the corpus

NCT07544056

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 2/3 TRIAL

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

ClinicalTrials.gov

This is a clinical trial registry record describing a planned Phase 2/3 interventional study with no results posted; the study is actively recruiting and outcome data have not yet been reported.

PreliminaryBeBetter Med Locally Advanced Triple Negative Breast Cancer BEBT-209 capsules

Reported

Estimated enrollment446

Primary outcome (Phase 2b)Objective Response Rate (ORR) per RECIST v1…

Primary outcome (Phase 3)Overall Survival (OS), measured from random…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support